Product Information

BENICAR 40 MG TABLET is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $15.6885 per EA under NDC 00713086230. Its NADAC has been published 175 times since Feb 22, 2023.

The High Outlier badge above means this manufacturer's average price in the olmesartan medoxomil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BENICAR 40 MG TABLET

olmesartan medoxomil
$15.6885per EA
High Outlier

Strength

40 mg/1

NDC

00713086230

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

New Drug (NDA)

FDA Application

NDA021286

On Market Since

9/1/2022

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for BENICAR 40 MG TABLET has been published 175 times since Feb 22, 2023, and over the history we have for it it has risen 32.8%. The table below summarizes its recorded NADAC range and movement.

Current price$15.6885 per EA
All-time high$15.6920 (May 13, 2026)
All-time low$11.8133 (Feb 22, 2023)
52-week high$15.6920
52-week low$14.2440
Median price$14.2420
Average price$13.7845
Largest weekly change+10.0% (Sep 25, 2024)
Weeks tracked175
Tracking sinceFeb 22, 2023

Price History

1W

0.0%

1M

+0.3%

3M

-0.0%

6M

-0.0%

1Y

+10.1%

3Y

+32.8%

5Y

N/A

All

+32.8%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BENICAR 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BENICAR 40 MG TABLET, manufactured by Cosette Pharmaceuticals, Inc., is $15.6885 per EA (NDC 00713086230), effective Jun 24, 2026.

How has the price of BENICAR 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for BENICAR 40 MG TABLET has risen 32.8%. It has been tracked across 175 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for BENICAR 40 MG TABLET?

Since Feb 22, 2023, the NADAC for BENICAR 40 MG TABLET has ranged from a low of $11.8133 (Feb 22, 2023) to a high of $15.6920 (May 13, 2026), with a median of $14.2420 per EA.

Are there cheaper alternatives to BENICAR 40 MG TABLET?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 40 MG TAB, is $0.1101 per EA — about 99% below BENICAR 40 MG TABLET.

Who manufactures BENICAR 40 MG TABLET?

BENICAR 40 MG TABLET (NDC 00713086230) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.